Ontology highlight
ABSTRACT: Purpose
We aimed to report the clinical and immunological characteristics of variant type X91+ chronic granulomatous disease (CGD) in a Chinese cohort.Methods
The clinical manifestations and immunological phenotypes of patients with X91+ CGD were collected. A dihydrorhodamine (DHR) analysis was performed to evaluate neutrophil function. Gp91phox protein expression was determined using extracellular staining with the monoclonal antibody (mAb) 7D5 and flow cytometry.Results
Patients with X91+ CGD accounted for 8% (7/85) of all patients with CGD. The median age of onset in the seven patients with X91+ CGD was 4 months. Six patients received the BCG vaccine, and 50% (3/6) had probable BCG infections. Mycobacterium tuberculosis infection was prominent. The most common sites of infection were the lung (6/7), lymph nodes (5/7), and soft tissue (3/7). Two patients experienced recurrent oral ulcers. The stimulation index (SI) of the patients with X91+ CGD ranged widely from 1.9 to 67.3. The difference in the SI among the three groups of patients (X91+ CGD, X91- CGD, and X910 CGD) was statistically significant (P = 0.0071). The three groups showed no significant differences in onset age, diagnosis age, or severe infection frequency. CYBB mutations associated with X91+ CGD were commonly located in the second transmembrane or intracellular regions. Three novel X91+ CGD-related mutations (c.1462-2 A > T, c.1243C > T, and c.925G > A) were identified.Conclusions
Variant type X91+ CGD may result in varied clinical manifestations. Moreover, the laboratory findings might indicate a moderate neutrophil SI. We should deepen our understanding of variant X91+ CGD to prevent missed diagnoses.
SUBMITTER: Sun B
PROVIDER: S-EPMC9674757 | biostudies-literature | 2022 Oct
REPOSITORIES: biostudies-literature
Journal of clinical immunology 20220707 7
<h4>Purpose</h4>We aimed to report the clinical and immunological characteristics of variant type X91<sup>+</sup> chronic granulomatous disease (CGD) in a Chinese cohort.<h4>Methods</h4>The clinical manifestations and immunological phenotypes of patients with X91<sup>+</sup> CGD were collected. A dihydrorhodamine (DHR) analysis was performed to evaluate neutrophil function. Gp91<sup>phox</sup> protein expression was determined using extracellular staining with the monoclonal antibody (mAb) 7D5 a ...[more]